A5024716664- Cancer Treatment and Pharmacology
- Prostate Cancer Treatment and Research
- Advanced Breast Cancer Therapies
- Bone health and treatments
- Hepatocellular Carcinoma Treatment and Prognosis
- HER2/EGFR in Cancer Research
- Complementary and Alternative Medicine Studies
- Management of metastatic bone disease
- Colorectal Cancer Treatments and Studies
- Economic and Financial Impacts of Cancer
- Healthcare and Venom Research
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Radiopharmaceutical Chemistry and Applications
- Pharmacological Effects of Natural Compounds
- Cancer survivorship and care
- Head and Neck Cancer Studies
Ospedali Riuniti Umberto I
2014-2020
Ospedale Antonio Cardarelli
2019
Introduction: The advent of oral chemotherapy agents has had a strong impact on several aspects the management cancer patients, including survival rates, health-care expenditure, and health-related quality life. However, access to care adherence are central optimal outcomes. Patients methods: In this multicenter observational study, we assessed effect “Active Home Care” initiative – structured, active, home-based cancer-treatment program life, utilization, patient satisfaction using...
In elderly patients affected by metastatic castration-resistant prostate cancer (mCRPC) chemotherapic treatment may be the choice if one considers not only chronological age, but also clinical status, functional reserve, and vulnerability of patients. Several studies have confirmed survival benefit docetaxel vinorelbine among every class age. Most CRP are defined as frail, maybe due to comorbidities: these patients, who unable candidates for a standard treatment, should more tolerable...
Treatment with radium-223 has been shown to increase survival and delay skeletal events related bone metastases of patients metastatic Castration Resistant Prostate Cancer (mCRPC). This treatment also proved be well tolerated, hematological toxicity, in particular anemia, represents the most represented adverse event.We evaluated hematologic toxicity Ra-223 a real-life experience 38 from two Italian cancer centers, mCRPC. The main endpoint study was evaluation efficacy tolerability...